
Cognition Therapeutics Set to Share Exciting Updates at the Life Sciences Virtual Investor Conference
Cognition Therapeutics: Unveiling the Future of Neurodegenerative Disorders Treatment PURCHASE, NY, March 10, 2025 – Cognition Therapeutics, Inc., a pioneering clinical-stage biotech company, is set to make significant strides in the neurodegenerative disorders landscape. On March 13, 2025, the Company’s President and CEO, Lisa Ricciardi, will present at the Life Sciences Virtual Investor Conference at…